36
Views
12
CrossRef citations to date
0
Altmetric
CASE REPORT

New‐onset, debilitating arthritis in psoriasis patients receiving efalizumab

, &
Pages 353-354 | Received 03 Jul 2006, Accepted 06 Jul 2006, Published online: 12 Jul 2009

References

  • Leonardi C. L. Treatment of psoriasis using efalizumab. Therapy of moderate‐to‐severe psoriasis, G. D Weinstein, A. B Gottlieb. Marcel Dekker, Inc, New York 2003; 333–50, 2nd ed
  • Genentech, Inc. Raptiva (efalizumab) package insert. South San Francisco, CA 2006
  • Siegmund K., Feuerer M., Siewert C., Ghani S., Haubold U., Dankof A., et al. Migration matters: Regulatory T cell compartmentalization determines suppressive activity in vivo. Blood 2005; 106: 3097–104
  • Huehn J., Siegmund K., Lehmann J. C., Siewert C., Haubold U., Feuerer M., et al. Developmental stage, phenotype, and migration distinguish naïve‐ and effector/memory‐like CD4+ regulatory cells. J Exp Med 2004; 199: 303–13

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.